ARCHIVES

Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing

This article is from The Cancer Letter archive.

Vol. 07 No. 09 | February 27, 1981

Download PDF Visit The Full Archive

Related Articles

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

Clinical Trials Approved By NCI CTEP During July

August 30, 2002

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

March 12, 1999

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

Business & Regulatory Report March edition (8 pages) included.

March 19, 2004